Published on 9 Mar 2024 on GuruFocus.com via Yahoo Finance
ANI Pharmaceuticals Inc CEO Nikhil Lalwani Sells 45,257 Shares
Nikhil Lalwani, President & CEO of ANI Pharmaceuticals Inc (NASDAQ:ANIP), executed a sale of 45,257 shares in the company on March 8, 2024, according to a recent SEC Filing. The transaction was carried out at an average price of $66.1 per share, resulting in a total value of approximately $2,991,488.7.
Warning! GuruFocus has detected 8 Warning Signs with ANIP.
ANI Pharmaceuticals Inc is a specialty pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded prescription pharmaceuticals. The company's focus is on producing a diversified portfolio of products in various therapeutic areas, including endocrinology, oncology, and dermatology, among others.